See more news releases in: Household, Consumer & Cosmetics, Health Care & Hospitals, Infection Control, New Products & Services
MyClyns(R) Now Available Nationwide for First Time to Consumers
Groundbreaking Germ Defense Spray Hits Shelves for First Time
CINCINNATI, Dec. 2 /PRNewswire/ --MyClyns, the new non-alcohol germ protection spray, is now available to consumers over the counter throughout the nation, after overwhelmingly positive consumer test marketing in Cincinnati and Cleveland. The MyClyns spray has been used and trusted by first responders, healthcare professionals, military and emergency workers nationally and even internationally for years, but is now available to consumers and on store shelves for the very first time.
(Photo: http://www.newscom.com/cgi-bin/prnh/20091202/CL20122)
MyClyns is the only germ protection spray that is safe for the eyes, nose, mouth and minor cuts and abrasions -- places where germs commonly enter the body. Developed by Northern Kentucky based Union Springs Pharmaceuticals, the solution found in MyClyns has shown a 99.99 percent reduction for most of the most threatening pathogens as validated in independent laboratory testing. Early movement of the product has seen a significant spike in demand with the onset of the cold and flu season.
"MyClyns found initial significant success with public safety officials, as they are frequently exposed to any number of nasty pathogens in the field," Union Springs Pharmaceuticals president Joel Ivers said. "That success led us logically to offer the same product to consumers and the response has been overwhelming. It is available in a convenient consumer package, giving parents and travelers another way to help protect themselves and their families when exposed to sick people or public locations where there are potentially harmful germs."
The solution in MyClyns is cleared by the FDA as a 510(k) medical device. It is currently used by more than 2,000 municipalities in the U.S. and 35 countries worldwide. For more information about MyClyns and Union Springs Pharmaceuticals visit www.Clyns.com.
About Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals specializes in providing innovative personal and environmental protection products for the EMS, fire, law enforcement, corrections, military, government, healthcare and consumer markets. Union Springs Pharmaceuticals currently markets MyClyns, the revolutionary personal protection spray that can be applied into the eyes, nose and mouth. The company also offers the T-5000 and T-5000V P95 respirators, the only disposable respirators with antimicrobial technology. It will launch its newest product, ViralClyns(TM), a more convenient N-95 respirator coated with the same antimicrobial later this quarter. More information on Union Springs Pharmaceuticals and its products can be found at www.ClynsBrands.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Joel Ivers
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=92110
SOURCE Union Springs Pharmaceuticals, LLC
Back to top
RELATED LINKS
http://www.Clyns.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".
- Site Preview
-
Close Site Preview
-
View FullScreen

